The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Digoxin. A neurohormonal modulator in heart failure?
Open accessAbstract
D igitalis preparations have been in clinical usefor more than 200 years.Despite extensive clinical use, controversy persists as to the precise indications for digoxin therapy in patients with chronic heart failure who are in sinus rhythm.'Clinical Use of Digitalis Glycosides The potential benefit of digoxin therapy in heart failure patients is thought to be related to its positive inotropic effect that increases cardiac output and thereby decreases ventricular filling pressures.2Al- though digoxin is undoubtedly an inotropic agent in tissue preparations,3 this effect, in contrast to other inotropic agents, is not consistently translated into improved hemodynamics in the intact animal or in humans.4For example, in normal volunteers5 or in patients with left ventricular dysfunction and normal6 or normalized hemodynamics with other therapies,7 no significant increase and even a decrease8 in car- diac output may occur.This paradox was initially attributed to peripheral vasoconstrictor9,10 effects of digitalis compounds that increase afterload and thereby attenuate or mask its inotropic effect.How- ever, peripheral vasoconstriction is transient1' and is manifested only after rapid intravenous administra- tion of digitalis preparations and does not fully explain the failure to augment cardiac function in patients with normal hemodynamics.In contrast, when digoxin is given acutely to pa- tients with left ventricular systolic dysfunction and abnormal central hemodynamics,12-14 there is a significant increase in cardiac output and a decrease in pulmonary capillary wedge pressure and systemic vascular resistance.It appears, therefore, that the acute hemodynamic response to digoxin is inversely proportional to the degree of underlying hemodynamic impairment.7Several studies have shown that long-term digoxin therapy improves left ventricular function and is clini-The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Cellular mechanism of action of cardiac glycosides
Fozzard, H. A., & Sheets, M. F. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80458-7 · Cited by 72
Cited by
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Idiopathic Dilated Cardiomyopathy
Dec, G. W., & Fuster, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412083312307 · Cited by 963
Metadata
- Authors
- Gheorghiade, M., & Ferguson, D.
- Venue
- Circulation
- Published
- 1991-11
- Volume
- 84
- Issue
- 5
- Pages
- 2181-2186
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2007803440
- Cited by
- 197
- References
- 2
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.